Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population;Funkcjonalny polimorfizm genu manganowej dysmutazy ponadtlenkowej (MnSOD) u chorych na schizofreniȩ w poiskiej populacji

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 329-332

  Gałecki, Piotr ^a,c   Pietras, Tadeusz ^a,b   Szemraj, Janusz ^a   Florkowska, Kinga ^a   Florkowski, Antoni ^a   Zboralski, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Medical University of Lodz Klinika Pneumonologii i Alergologii   (Poland)

^c Klinika Psychiatrii i Zaburzen Nerwicowych z Oddzialem Interwencji Kryzysowych   (Poland)

Author keywords

Manganese superoxide dismutase; Polymorphism; Schizophrenia

Indexed keywords

ALANINE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; VALINE;

ADULT; ALLELE; APOPTOSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARANOID SCHIZOPHRENIA; POLAND; POSITIVE AND NEGATIVE SYNDROME SCALE; RISK ASSESSMENT; SCHIZOPHRENIA;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLAND; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; VARIATION (GENETICS);

EID: 33645664296     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Akyol O., Herken H., Uz E., i wsp.: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog. Neuropharmacol. Biol. Psychiatry., 2002, 26, 995-1005.
2. Akyol O., Yanik M., Elyas H., Namli M., Cnatan H., Zoroglu S.S.: Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry., 2005, 29, 123-31.
3. Ambrosone C.B., Freudeinheim J.B., Thompsom P.A., Bowman E.: Manganese superoxide dismutase (MnSOD) genetic polymorphism, dietary antioxidants, and risk of breast cancer. Cancer Research, 1999, 59, 602-6.
4. Bartosz G.: Druga twarz tlenu. Wydawnictwo Naukowe PWN, 1995.
5. Borgstahl G.E.O., Parge H.E., Hickey M.J., Johnson M.J., Boissinot M., Hallewell R.A.: Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destablising the tetrameric interface. Biocemistry, 1996, 43, 863-7.
6. Church S.L., Grant J.W., Meese E.U., Trent J.M.: Sublocalization of the gene encoding manganese superoxide dismutase(MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. 1992, 14, 823-5.
7. Coyle J.T., Puttfacken P.: Oxidative stress, glutamate, and neurodegenerative disorders. Science, 1993, 262, 289-95.
8. Gałecki P., Florkowski A., Zboralski K.: Generowanie anionorodnika ponadtlenkowego i aktywność dysmutazy ponadtlenkowej we krwi u pacjentów ze schizofrenia̧. Valetudinaria. Post. Med. Klin. Wojsk., 2005, 1, 25-8.
9. Gałecki P., Nowakowski T.: Trace elements (copper, zinc) content and superoxide dismutase activity in erythrocytes from schizophrenic patients. Acta Psychiatrica Scandinavica, Supl. 2004, 421, 14.
10. Halliwell B.: Reactive oxygen species and the central nervous system. J. Neurochem., 1992, 59, 1609-23.
11. Herken H., Uz E., Ozyurt H., i wsp.: Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry, 2001, 6, 66-7.
12. Herrlich P., Bohmer F.D.: Redox regulation of signal transduction in mammalian cells. Biochem. Farmacol., 2000, 59, 35-41.
13. Hori H., Ohmori O., Shinakai T., Kojima H., Okano C., Suzuki T., Nakamura J.: Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacol., 2000, 23, 170-176.
14. Kahl R., Kampkotter A., Watjen W., Chovolou Y.: Antioxidant enzymes and apoptosis. Drug Metabolism Reviews, 2004, 36, 747-62.
15. Kay S.R., Opler L.A.: Positive and Negative Syndrome Scale (PANSS) Rating Manual. San Rafael CA: Social and Behavioral Sciences Documents, 1987.
16. Keller J.N., Kindy M.S., Holtsberg F.W., Clair D.K.: Mitochondrial manganese superoxide dismutase prevents neuronal apoptosis and reduces ischemic brain injury: Suppression of peroxinitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neuroscience, 1998, 2, 687-97.
17. Kelly J., Murray R.M.: What risk factor tell as about the causes of schizophrenia and related psychoses. 2001, 4, 4-16.
18. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania w ICD-10. Opisy kliniczne i wskazówki diagnostyczne. Uniwersyteckie Wydawnictwo Medyczne "Vesalius", 1997.
19. Kuloglu M., Ustundag B., Atnaca M.: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem. Funct., 2002, 20, 171-5.
20. Lemire B.D., Fankhauser C., Baker A., Schatz G.: The mitochondrial targeting function of randomly generated peptide sequences correlates with predicted helical amphiphilicity. J. Biol. Chem., 1989, 264, 20206-15.
21. Liberman J.A., Sheitman B.B., Kiton B.J.: Neurochemical sensitization in the pathophysiology in schizophrenia: deficits and dysfunction in normal regulation and plasticity. Neuropsychopharmacol., 1997, 17, 205-29.
22. Liczmański A.E.: Toksyczność tlenu. II. Mechanizmy obronne. Post. Biochem., 1988, 34, 293-310.
23. Matsumine H., Saito M., Shimoda-Matsubayashi S., Tanaka H., Ishikawa A.: Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27. Am. J. Hum. Genet., 1997, 60, 588-96.
24. Modlin S.O., Gottesman I.I.: At issue: genes, experience, and chance in schizophrenia - positioning for the 21st century. Schizophr. Bull., 1997, 23, 547-61.
25. Parikh V., Khan M.M., Mahadik S.P.: Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J. Psychiatr. Res., 2003, 37, 43-51.
26. Rosen D.R.: Mutation Cu/Zn superoxide dismutase gene are assosiated with familiar amylotrophic lateral sclerosis. Nature, 1993, 352, 59-62.
27. Sambrook J., Russell D.W.: Molecular Clonning. A laboratory Mannual. 2001, Cold Spring Harbor Laboratory Press, Cold Spring Halbor, New York, USA.
28. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y.: Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun., 1996, 226, 561-5.
29. Svejgaard I.: HLA and disease, 1982 - a survey. Immunol. Rev., 1983, 70, 193.
30. Tsai G., Coyle J.T.: N-Acetyaspartate in neuropsychiatric disorders. Prog. Neurobiol., 1995, 46, 531-40.
31. Wang E., Cortopassi G.: Mice with duplications and delections at the Tme locus have alerted MnSOD activity. J. Biol. Chem., 1994, 269, 22463-5.
32. Weinberger D.R.: From neuropathology to neurodevelopment. Lancet, 1995, 346, 552-7.
33. Van-Landeghem G.F., Tabatabaie P., Beckman G., Beckman L., Andersen P.M.: Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum. Heredity, 1999, 49, 190-3.
34. Zhang Z.J., Zhang X.B., Hou G., Sha W.W., Reynolds G.P.: The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. J. Psychiatr. Res., 2002, 26, 317-24.
35. Zelko I.N., Mariani T.J., Folz R.J.: Superoxide dismutase multigene family: A comparison of the Cu,ZnSOD (sod1), Mn-SOD (sod2), and EC-SOD (sod3) gene structures, evolution, and expression. Free Radic. Biol. Med., 2002, 33, 337-49.